The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck
Exclusive distribution pact with Amcor broadens access to Parafilm M sealing solutions for laboratories, horticulture and industrial users
Backed by funding from an NIHR Doctoral Award, the guidance is focused on spotting abdominal tumours
Paves the way for next-gen ultra-precise gas sensing
BioNTech will supply pumitamig, a PD-L1/VEGF-A bispecific antibody co-developed with Bristol Myers Squibb, while Boehringer Ingelheim will act as the regulatory sponsor of a Phase Ib/II study
At India Pharma 2026, Dr Bahl calls for experimentation over imitation as funding rises and translational ecosystem reforms gather pace
Panacea Biotec receives LoA from CMSS
The FDA is also reviewing the application under its Real-Time Oncology Review (RTOR) program and Project Orbis
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
The campaign builds on the three-year partnership unveiled earlier this season
Subscribe To Our Newsletter & Stay Updated
